ABT vs SHIM · P/E 25, rev $44.33B vs rev $492.8M
Abbott Laboratories (ABT) versus Shimmick Corporation Common Stock (SHIM) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Shimmick Corporation Common Stock (SHIM) is a engineering & construction company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported SHIM revenue for 2026-01-02 was $492.8M. Net income was -$25.6M. Revenue was up 2.6% from 2025-01-03 to 2026-01-02. SHIM currently screens at market cap $158.2M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. SHIM currently screens at market cap $158.2M.
Not investment advice. Open the ABT and SHIM stock pages for the full models.
Not investment advice.